Relationship Between O6-Alkylguanine-DNA Alkyltransferase Activity and N-Methyl-N'-Nitro-N-Nitrosoguanidine-Induced Mutation, Transformation, and Cytotoxicity in C3H/10T1/2 Cells Expressing Exogenous Alkyltransferase Genes

While a great deal of evidence has directly implicated the importance of O6-alkylation of guanine in the mutagenicity of alkylating agents, evidence demonstrating the oncogenic potential of this lesion has been largely indirect. We have combined a well-studied in vitro neoplastic transformation syst...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Proceedings of the National Academy of Sciences - PNAS 1992-12, Vol.89 (23), p.11199-11203
Hauptverfasser: von Hofe, Eric, Fairbairn, Leslie, Margison, Geoffrey P.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 11203
container_issue 23
container_start_page 11199
container_title Proceedings of the National Academy of Sciences - PNAS
container_volume 89
creator von Hofe, Eric
Fairbairn, Leslie
Margison, Geoffrey P.
description While a great deal of evidence has directly implicated the importance of O6-alkylation of guanine in the mutagenicity of alkylating agents, evidence demonstrating the oncogenic potential of this lesion has been largely indirect. We have combined a well-studied in vitro neoplastic transformation system (using C3H/10T1/2 mouse cells) with a proven method of gene transfection for expressing the bacterial O6-alkylguanine-DNA alkyltransferase (AT; EC 2.1.1.63) repair genes ada and ogt to generate subclones which possess augmented repair capability toward specific DNA lesions. The products of these genes specifically and differentially repair O6-methylguanine (O6-MeGua), O4-methylthymine (O4-MeThy), and methylphos-photriesters. We show that the level of expression of either the ada or the ogt AT gene in C3H/10T1/2 cells directly correlates with protection against mutation to ouabain resistance by N-methyl-N'-nitro-N-nitrosoguanidine (MNNG). Subclones expressing 70 fmol of AT per 106cells exhibited a mutation frequency approximately 1/40th of that of clones expressing 15 fmol of AT per 106cells when treated with MNNG at 0.4 μ g/ml. Protection against mutagenesis by MNNG at 0.8 μg/ml, however, did not exceed 12-fold even in subclones expressing greater than 100 fmol of AT per 106cells. As an MNNG dose of 0.6 μ g/ml was sufficient to saturate more than 95% of the AT activity in any of the clones, the residual mutation frequency may have been caused by unrepaired O6MeGua lesions. In contrast to mutagenesis, protection against neoplastic transformation in vitro, in cells expressing high levels of AT, was most pronounced in cells treated with the highest dose of MNNG used (1.2 μg/ml). Low levels of transformation caused by MNNG at 0.4 and 0.8 μg/ml were not consistently inhibited in those clones. These data suggest that O6-MeGua formation is of major but not unique significance in the neoplastic transformation of C3H/10T1/2 cells by MNNG.
doi_str_mv 10.1073/pnas.89.23.11199
format Article
fullrecord <record><control><sourceid>jstor_cross</sourceid><recordid>TN_cdi_jstor_primary_2360674</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>2360674</jstor_id><sourcerecordid>2360674</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3439-b1c6209c271ea9161ffae5317d3dd6b8a0b7072cc61f5f7ba4ee990be29db4653</originalsourceid><addsrcrecordid>eNp9UctuEzEUHSFQCYU9CxBeIJUFTvyYRyyxSUNpK7WphMLa8njuJC6OHY09JflZvoWZJAQqJFZ-nNfVPUnympIhJQUfrZ0Kw7EYMj6klArxJBlQIijOU0GeJgNCWIHHKUufJy9CuCeEiGxMTpITmmZpIcQg-fkVrIrGu7A0a3QO8QeAQ3c5ntjvW7tolTMO8OfZBO0-YqNcqKFRAdBER_Ng4hYpV6EZvoW43Fo8O8MzExuPZ_sz-J1J1dtcu6rVUKHbNu4yP6L5zs83q8O7t5puo49-Y3TvbRya8qsRJXM6YmgK1gZ0sVk3EIJxi-7qF-B8G_4d7xIchJfJs1rZAK8O52ny7cvFfHqFb-4ur6eTG6x5ygUuqc4ZEZoVFJSgOa1rBRmnRcWrKi_HipQFKZjWHZLVRalSACFICUxUZZpn_DT5tPddt-UKKg2uG8XKdWNWqtlKr4x8jDizlAv_IDOS0aKTk71cdwsLDdRHJSWyL1r2RcuxkIzLXdGd5O3fiX8E-2Y7_P0BV0ErW3eb0SYcaWnGRJbnHe3dgdYH_EYfB334P0PWrbURNrGjvtlT70P0zZHLeE7yIuW_APZs2WQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Relationship Between O6-Alkylguanine-DNA Alkyltransferase Activity and N-Methyl-N'-Nitro-N-Nitrosoguanidine-Induced Mutation, Transformation, and Cytotoxicity in C3H/10T1/2 Cells Expressing Exogenous Alkyltransferase Genes</title><source>Jstor Complete Legacy</source><source>MEDLINE</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><source>Free Full-Text Journals in Chemistry</source><creator>von Hofe, Eric ; Fairbairn, Leslie ; Margison, Geoffrey P.</creator><creatorcontrib>von Hofe, Eric ; Fairbairn, Leslie ; Margison, Geoffrey P.</creatorcontrib><description>While a great deal of evidence has directly implicated the importance of O6-alkylation of guanine in the mutagenicity of alkylating agents, evidence demonstrating the oncogenic potential of this lesion has been largely indirect. We have combined a well-studied in vitro neoplastic transformation system (using C3H/10T1/2 mouse cells) with a proven method of gene transfection for expressing the bacterial O6-alkylguanine-DNA alkyltransferase (AT; EC 2.1.1.63) repair genes ada and ogt to generate subclones which possess augmented repair capability toward specific DNA lesions. The products of these genes specifically and differentially repair O6-methylguanine (O6-MeGua), O4-methylthymine (O4-MeThy), and methylphos-photriesters. We show that the level of expression of either the ada or the ogt AT gene in C3H/10T1/2 cells directly correlates with protection against mutation to ouabain resistance by N-methyl-N'-nitro-N-nitrosoguanidine (MNNG). Subclones expressing 70 fmol of AT per 106cells exhibited a mutation frequency approximately 1/40th of that of clones expressing 15 fmol of AT per 106cells when treated with MNNG at 0.4 μ g/ml. Protection against mutagenesis by MNNG at 0.8 μg/ml, however, did not exceed 12-fold even in subclones expressing greater than 100 fmol of AT per 106cells. As an MNNG dose of 0.6 μ g/ml was sufficient to saturate more than 95% of the AT activity in any of the clones, the residual mutation frequency may have been caused by unrepaired O6MeGua lesions. In contrast to mutagenesis, protection against neoplastic transformation in vitro, in cells expressing high levels of AT, was most pronounced in cells treated with the highest dose of MNNG used (1.2 μg/ml). Low levels of transformation caused by MNNG at 0.4 and 0.8 μg/ml were not consistently inhibited in those clones. These data suggest that O6-MeGua formation is of major but not unique significance in the neoplastic transformation of C3H/10T1/2 cells by MNNG.</description><identifier>ISSN: 0027-8424</identifier><identifier>EISSN: 1091-6490</identifier><identifier>DOI: 10.1073/pnas.89.23.11199</identifier><identifier>PMID: 1454799</identifier><identifier>CODEN: PNASA6</identifier><language>eng</language><publisher>Washington, DC: National Academy of Sciences of the United States of America</publisher><subject>Animals ; Biological and medical sciences ; Carcinogenesis ; Carcinogenesis, carcinogens and anticarcinogens ; Cell culture techniques ; Cell Cycle ; Cell lines ; Cell Survival - drug effects ; Cell Transformation, Neoplastic - drug effects ; Cells ; Cells, Cultured ; Chemical agents ; Cytotoxicity ; DNA Damage ; DNA Repair ; Doubling time ; Genes ; Genetic mutation ; In Vitro Techniques ; Lesions ; Medical sciences ; Methylnitronitrosoguanidine - pharmacology ; Methyltransferases - genetics ; Methyltransferases - metabolism ; Mice ; Mutagenesis ; O-Methylguanine-DNA Methyltransferase ; Transfection ; Tumors</subject><ispartof>Proceedings of the National Academy of Sciences - PNAS, 1992-12, Vol.89 (23), p.11199-11203</ispartof><rights>Copyright 1992 The National Academy of Sciences of the United States of America</rights><rights>1993 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3439-b1c6209c271ea9161ffae5317d3dd6b8a0b7072cc61f5f7ba4ee990be29db4653</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Uhttp://www.pnas.org/content/89/23.cover.gif</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/2360674$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/2360674$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>230,314,723,776,780,799,881,27901,27902,53766,53768,57992,58225</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=4529566$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/1454799$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>von Hofe, Eric</creatorcontrib><creatorcontrib>Fairbairn, Leslie</creatorcontrib><creatorcontrib>Margison, Geoffrey P.</creatorcontrib><title>Relationship Between O6-Alkylguanine-DNA Alkyltransferase Activity and N-Methyl-N'-Nitro-N-Nitrosoguanidine-Induced Mutation, Transformation, and Cytotoxicity in C3H/10T1/2 Cells Expressing Exogenous Alkyltransferase Genes</title><title>Proceedings of the National Academy of Sciences - PNAS</title><addtitle>Proc Natl Acad Sci U S A</addtitle><description>While a great deal of evidence has directly implicated the importance of O6-alkylation of guanine in the mutagenicity of alkylating agents, evidence demonstrating the oncogenic potential of this lesion has been largely indirect. We have combined a well-studied in vitro neoplastic transformation system (using C3H/10T1/2 mouse cells) with a proven method of gene transfection for expressing the bacterial O6-alkylguanine-DNA alkyltransferase (AT; EC 2.1.1.63) repair genes ada and ogt to generate subclones which possess augmented repair capability toward specific DNA lesions. The products of these genes specifically and differentially repair O6-methylguanine (O6-MeGua), O4-methylthymine (O4-MeThy), and methylphos-photriesters. We show that the level of expression of either the ada or the ogt AT gene in C3H/10T1/2 cells directly correlates with protection against mutation to ouabain resistance by N-methyl-N'-nitro-N-nitrosoguanidine (MNNG). Subclones expressing 70 fmol of AT per 106cells exhibited a mutation frequency approximately 1/40th of that of clones expressing 15 fmol of AT per 106cells when treated with MNNG at 0.4 μ g/ml. Protection against mutagenesis by MNNG at 0.8 μg/ml, however, did not exceed 12-fold even in subclones expressing greater than 100 fmol of AT per 106cells. As an MNNG dose of 0.6 μ g/ml was sufficient to saturate more than 95% of the AT activity in any of the clones, the residual mutation frequency may have been caused by unrepaired O6MeGua lesions. In contrast to mutagenesis, protection against neoplastic transformation in vitro, in cells expressing high levels of AT, was most pronounced in cells treated with the highest dose of MNNG used (1.2 μg/ml). Low levels of transformation caused by MNNG at 0.4 and 0.8 μg/ml were not consistently inhibited in those clones. These data suggest that O6-MeGua formation is of major but not unique significance in the neoplastic transformation of C3H/10T1/2 cells by MNNG.</description><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Carcinogenesis</subject><subject>Carcinogenesis, carcinogens and anticarcinogens</subject><subject>Cell culture techniques</subject><subject>Cell Cycle</subject><subject>Cell lines</subject><subject>Cell Survival - drug effects</subject><subject>Cell Transformation, Neoplastic - drug effects</subject><subject>Cells</subject><subject>Cells, Cultured</subject><subject>Chemical agents</subject><subject>Cytotoxicity</subject><subject>DNA Damage</subject><subject>DNA Repair</subject><subject>Doubling time</subject><subject>Genes</subject><subject>Genetic mutation</subject><subject>In Vitro Techniques</subject><subject>Lesions</subject><subject>Medical sciences</subject><subject>Methylnitronitrosoguanidine - pharmacology</subject><subject>Methyltransferases - genetics</subject><subject>Methyltransferases - metabolism</subject><subject>Mice</subject><subject>Mutagenesis</subject><subject>O-Methylguanine-DNA Methyltransferase</subject><subject>Transfection</subject><subject>Tumors</subject><issn>0027-8424</issn><issn>1091-6490</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1992</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9UctuEzEUHSFQCYU9CxBeIJUFTvyYRyyxSUNpK7WphMLa8njuJC6OHY09JflZvoWZJAQqJFZ-nNfVPUnympIhJQUfrZ0Kw7EYMj6klArxJBlQIijOU0GeJgNCWIHHKUufJy9CuCeEiGxMTpITmmZpIcQg-fkVrIrGu7A0a3QO8QeAQ3c5ntjvW7tolTMO8OfZBO0-YqNcqKFRAdBER_Ng4hYpV6EZvoW43Fo8O8MzExuPZ_sz-J1J1dtcu6rVUKHbNu4yP6L5zs83q8O7t5puo49-Y3TvbRya8qsRJXM6YmgK1gZ0sVk3EIJxi-7qF-B8G_4d7xIchJfJs1rZAK8O52ny7cvFfHqFb-4ur6eTG6x5ygUuqc4ZEZoVFJSgOa1rBRmnRcWrKi_HipQFKZjWHZLVRalSACFICUxUZZpn_DT5tPddt-UKKg2uG8XKdWNWqtlKr4x8jDizlAv_IDOS0aKTk71cdwsLDdRHJSWyL1r2RcuxkIzLXdGd5O3fiX8E-2Y7_P0BV0ErW3eb0SYcaWnGRJbnHe3dgdYH_EYfB334P0PWrbURNrGjvtlT70P0zZHLeE7yIuW_APZs2WQ</recordid><startdate>19921201</startdate><enddate>19921201</enddate><creator>von Hofe, Eric</creator><creator>Fairbairn, Leslie</creator><creator>Margison, Geoffrey P.</creator><general>National Academy of Sciences of the United States of America</general><general>National Acad Sciences</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>19921201</creationdate><title>Relationship Between O6-Alkylguanine-DNA Alkyltransferase Activity and N-Methyl-N'-Nitro-N-Nitrosoguanidine-Induced Mutation, Transformation, and Cytotoxicity in C3H/10T1/2 Cells Expressing Exogenous Alkyltransferase Genes</title><author>von Hofe, Eric ; Fairbairn, Leslie ; Margison, Geoffrey P.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3439-b1c6209c271ea9161ffae5317d3dd6b8a0b7072cc61f5f7ba4ee990be29db4653</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1992</creationdate><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Carcinogenesis</topic><topic>Carcinogenesis, carcinogens and anticarcinogens</topic><topic>Cell culture techniques</topic><topic>Cell Cycle</topic><topic>Cell lines</topic><topic>Cell Survival - drug effects</topic><topic>Cell Transformation, Neoplastic - drug effects</topic><topic>Cells</topic><topic>Cells, Cultured</topic><topic>Chemical agents</topic><topic>Cytotoxicity</topic><topic>DNA Damage</topic><topic>DNA Repair</topic><topic>Doubling time</topic><topic>Genes</topic><topic>Genetic mutation</topic><topic>In Vitro Techniques</topic><topic>Lesions</topic><topic>Medical sciences</topic><topic>Methylnitronitrosoguanidine - pharmacology</topic><topic>Methyltransferases - genetics</topic><topic>Methyltransferases - metabolism</topic><topic>Mice</topic><topic>Mutagenesis</topic><topic>O-Methylguanine-DNA Methyltransferase</topic><topic>Transfection</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>von Hofe, Eric</creatorcontrib><creatorcontrib>Fairbairn, Leslie</creatorcontrib><creatorcontrib>Margison, Geoffrey P.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Proceedings of the National Academy of Sciences - PNAS</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>von Hofe, Eric</au><au>Fairbairn, Leslie</au><au>Margison, Geoffrey P.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Relationship Between O6-Alkylguanine-DNA Alkyltransferase Activity and N-Methyl-N'-Nitro-N-Nitrosoguanidine-Induced Mutation, Transformation, and Cytotoxicity in C3H/10T1/2 Cells Expressing Exogenous Alkyltransferase Genes</atitle><jtitle>Proceedings of the National Academy of Sciences - PNAS</jtitle><addtitle>Proc Natl Acad Sci U S A</addtitle><date>1992-12-01</date><risdate>1992</risdate><volume>89</volume><issue>23</issue><spage>11199</spage><epage>11203</epage><pages>11199-11203</pages><issn>0027-8424</issn><eissn>1091-6490</eissn><coden>PNASA6</coden><abstract>While a great deal of evidence has directly implicated the importance of O6-alkylation of guanine in the mutagenicity of alkylating agents, evidence demonstrating the oncogenic potential of this lesion has been largely indirect. We have combined a well-studied in vitro neoplastic transformation system (using C3H/10T1/2 mouse cells) with a proven method of gene transfection for expressing the bacterial O6-alkylguanine-DNA alkyltransferase (AT; EC 2.1.1.63) repair genes ada and ogt to generate subclones which possess augmented repair capability toward specific DNA lesions. The products of these genes specifically and differentially repair O6-methylguanine (O6-MeGua), O4-methylthymine (O4-MeThy), and methylphos-photriesters. We show that the level of expression of either the ada or the ogt AT gene in C3H/10T1/2 cells directly correlates with protection against mutation to ouabain resistance by N-methyl-N'-nitro-N-nitrosoguanidine (MNNG). Subclones expressing 70 fmol of AT per 106cells exhibited a mutation frequency approximately 1/40th of that of clones expressing 15 fmol of AT per 106cells when treated with MNNG at 0.4 μ g/ml. Protection against mutagenesis by MNNG at 0.8 μg/ml, however, did not exceed 12-fold even in subclones expressing greater than 100 fmol of AT per 106cells. As an MNNG dose of 0.6 μ g/ml was sufficient to saturate more than 95% of the AT activity in any of the clones, the residual mutation frequency may have been caused by unrepaired O6MeGua lesions. In contrast to mutagenesis, protection against neoplastic transformation in vitro, in cells expressing high levels of AT, was most pronounced in cells treated with the highest dose of MNNG used (1.2 μg/ml). Low levels of transformation caused by MNNG at 0.4 and 0.8 μg/ml were not consistently inhibited in those clones. These data suggest that O6-MeGua formation is of major but not unique significance in the neoplastic transformation of C3H/10T1/2 cells by MNNG.</abstract><cop>Washington, DC</cop><pub>National Academy of Sciences of the United States of America</pub><pmid>1454799</pmid><doi>10.1073/pnas.89.23.11199</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0027-8424
ispartof Proceedings of the National Academy of Sciences - PNAS, 1992-12, Vol.89 (23), p.11199-11203
issn 0027-8424
1091-6490
language eng
recordid cdi_jstor_primary_2360674
source Jstor Complete Legacy; MEDLINE; PubMed Central; Alma/SFX Local Collection; Free Full-Text Journals in Chemistry
subjects Animals
Biological and medical sciences
Carcinogenesis
Carcinogenesis, carcinogens and anticarcinogens
Cell culture techniques
Cell Cycle
Cell lines
Cell Survival - drug effects
Cell Transformation, Neoplastic - drug effects
Cells
Cells, Cultured
Chemical agents
Cytotoxicity
DNA Damage
DNA Repair
Doubling time
Genes
Genetic mutation
In Vitro Techniques
Lesions
Medical sciences
Methylnitronitrosoguanidine - pharmacology
Methyltransferases - genetics
Methyltransferases - metabolism
Mice
Mutagenesis
O-Methylguanine-DNA Methyltransferase
Transfection
Tumors
title Relationship Between O6-Alkylguanine-DNA Alkyltransferase Activity and N-Methyl-N'-Nitro-N-Nitrosoguanidine-Induced Mutation, Transformation, and Cytotoxicity in C3H/10T1/2 Cells Expressing Exogenous Alkyltransferase Genes
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T00%3A36%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Relationship%20Between%20O6-Alkylguanine-DNA%20Alkyltransferase%20Activity%20and%20N-Methyl-N'-Nitro-N-Nitrosoguanidine-Induced%20Mutation,%20Transformation,%20and%20Cytotoxicity%20in%20C3H/10T1/2%20Cells%20Expressing%20Exogenous%20Alkyltransferase%20Genes&rft.jtitle=Proceedings%20of%20the%20National%20Academy%20of%20Sciences%20-%20PNAS&rft.au=von%20Hofe,%20Eric&rft.date=1992-12-01&rft.volume=89&rft.issue=23&rft.spage=11199&rft.epage=11203&rft.pages=11199-11203&rft.issn=0027-8424&rft.eissn=1091-6490&rft.coden=PNASA6&rft_id=info:doi/10.1073/pnas.89.23.11199&rft_dat=%3Cjstor_cross%3E2360674%3C/jstor_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/1454799&rft_jstor_id=2360674&rfr_iscdi=true